Time slot's time in Taipei (GMT+8)
2025/11/21 14:00-17:30 Room 201 ABC
- Kick-on Seminar VII
Artificial Intelligence (AI): The Roadmap for Precision Medicine and Individualized Management
- Time
- Topic
- Speaker
- Moderator
- 15:00-15:30
- Artificial intelligence in neurophysiology: why does it matter and what is the appraisal?
- Speaker:
Tsung-Lin Lee
(Taiwan)
- Moderator:
Pei-Hao Chen
(Taiwan)
- Pei-Hao Chen
- MD, PhD
-
Director, Dementia Prevention and Treatment Center, MacKay Memorial Hospital
E-mail：a7662888@gmail.com
Executive Summary：
Dr. Pei-Hao Chen is a distinguished neurologist and researcher based at MacKay Memorial Hospital in Taipei, Taiwan, where he currently serves as Director of the Dementia Prevention and Treatment Center. He is also an Adjunct Associate Professor at MacKay Medical College. With over two decades of clinical experience and leadership in neurology, Dr. Chen specializes in dementia, Parkinson's disease, and related neurodegenerative disorders.
Dr. Chen is renowned for his integrative research bridging clinical neurology with engineering and data science. He has published extensively on gait analysis, blood biomarkers, and machine learning for predicting cognitive decline, with multiple first- or corresponding-author papers in high-impact journals. He also holds patents for innovative mobility-assistive devices.
In addition to his clinical and research roles, Dr. Chen is a key figure in national policy, serving as Convener of the Public Policy Committee of the Taiwan Dementia Society and Chairperson of the Neurorehabilitation, Long-term Care, and Gerontology Group of the Taiwan Neurological Society. His recent government-funded projects focus on multimodal prediction models and brain stimulation for cognitive enhancement.
Dr. Pei-Hao Chen is a distinguished neurologist and researcher based at MacKay Memorial Hospital in Taipei, Taiwan, where he currently serves as Director of the Dementia Prevention and Treatment Center. He is also an Adjunct Associate Professor at MacKay Medical College. With over two decades of clinical experience and leadership in neurology, Dr. Chen specializes in dementia, Parkinson's disease, and related neurodegenerative disorders.
Dr. Chen is renowned for his integrative research bridging clinical neurology with engineering and data science. He has published extensively on gait analysis, blood biomarkers, and machine learning for predicting cognitive decline, with multiple first- or corresponding-author papers in high-impact journals. He also holds patents for innovative mobility-assistive devices.
In addition to his clinical and research roles, Dr. Chen is a key figure in national policy, serving as Convener of the Public Policy Committee of the Taiwan Dementia Society and Chairperson of the Neurorehabilitation, Long-term Care, and Gerontology Group of the Taiwan Neurological Society. His recent government-funded projects focus on multimodal prediction models and brain stimulation for cognitive enhancement.
